Quest Diagnostics, Inc. DGX
The next Quest Diagnostics, Inc. dividend will go ex in 4 days for 56c and will be paid in 19 days.
The previous Quest Diagnostics, Inc. dividend was 56c and it went ex 3 months ago and it was paid 3 months ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 3.1.
|Summary||Previous dividend||Next dividend|
|Declaration date||18 Aug 2020 (Tue)||18 Nov 2020 (Wed)|
|Ex-div date||05 Oct 2020 (Mon)||19 Jan 2021 (Tue)|
|Pay date||21 Oct 2020 (Wed)||03 Feb 2021 (Wed)|
Enter the number of Quest Diagnostics, Inc. shares you hold and we'll calculate your dividend payments:
Sign up for Quest Diagnostics, Inc. and we'll email you the dividend information when they declare.
Add Quest Diagnostics, Inc. to receive free notifications when they declare their dividends.
Your account is set up to receive Quest Diagnostics, Inc. notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Quarterly||13 Nov 2024||14 Jan 2025||29 Jan 2025||USD||Sign up||—|
|Forecast||Quarterly||13 Aug 2024||30 Sep 2024||15 Oct 2024||USD||Sign up||—|
|Forecast||Quarterly||13 May 2024||02 Jul 2024||17 Jul 2024||USD||Sign up||—|
|Forecast||Quarterly||25 Jan 2024||01 Apr 2024||16 Apr 2024||USD||Sign up||—|
|Forecast||Quarterly||15 Nov 2023||16 Jan 2024||31 Jan 2024||USD||Sign up||—|
|Forecast||Quarterly||15 Aug 2023||02 Oct 2023||18 Oct 2023||USD||Sign up||—|
|Forecast||Quarterly||15 May 2023||03 Jul 2023||19 Jul 2023||USD||Sign up||—|
|Forecast||Quarterly||26 Jan 2023||03 Apr 2023||18 Apr 2023||USD||Sign up||—|
|Forecast||Quarterly||16 Nov 2022||17 Jan 2023||01 Feb 2023||USD||Sign up||—|
|Forecast||Quarterly||16 Aug 2022||03 Oct 2022||19 Oct 2022||USD||Sign up||—|
|Forecast||Quarterly||16 May 2022||05 Jul 2022||20 Jul 2022||USD||Sign up||—|
|Forecast||Quarterly||27 Jan 2022||04 Apr 2022||19 Apr 2022||USD||Sign up||—|
|Forecast||Quarterly||17 Nov 2021||18 Jan 2022||02 Feb 2022||USD||Sign up||—|
|Forecast||Quarterly||17 Aug 2021||04 Oct 2021||20 Oct 2021||USD||Sign up||—|
|Forecast||Quarterly||17 May 2021||06 Jul 2021||21 Jul 2021||USD||Sign up||—|
|Forecast||Quarterly||28 Jan 2021||05 Apr 2021||20 Apr 2021||USD||Sign up||—|
|Declared||Quarterly||18 Nov 2020||19 Jan 2021||03 Feb 2021||USD||56c||56c||😄|
|Paid||Quarterly||18 Aug 2020||05 Oct 2020||21 Oct 2020||USD||56c||56c||😄|
|Paid||Quarterly||18 May 2020||07 Jul 2020||22 Jul 2020||USD||56c||56c||😄|
|Paid||Quarterly||30 Jan 2020||06 Apr 2020||21 Apr 2020||USD||58c||56c||😃|
|Paid||Quarterly||20 Nov 2019||13 Jan 2020||29 Jan 2020||USD||56c||53c||😊|
|Paid||Quarterly||15 Aug 2019||03 Oct 2019||21 Oct 2019||USD||53c||53c||😄|
|Paid||Quarterly||14 May 2019||05 Jul 2019||22 Jul 2019||USD||—||53c|
|Paid||Quarterly||01 Mar 2019||05 Apr 2019||22 Apr 2019||USD||—||53c|
|Paid||Quarterly||28 Nov 2018||14 Jan 2019||30 Jan 2019||USD||—||53c|
|Paid||Quarterly||17 Aug 2018||04 Oct 2018||22 Oct 2018||USD||—||50c|
|Paid||Quarterly||14 May 2018||06 Jul 2018||23 Jul 2018||USD||—||50c|
|Paid||Quarterly||01 Feb 2018||03 Apr 2018||18 Apr 2018||USD||—||50c|
|Paid||Quarterly||29 Nov 2017||08 Jan 2018||24 Jan 2018||USD||—||45c|
|Paid||Quarterly||18 Aug 2017||02 Oct 2017||18 Oct 2017||USD||—||45c|
|Paid||Quarterly||16 May 2017||06 Jul 2017||24 Jul 2017||USD||—||45c|
|Paid||Quarterly||21 Feb 2017||03 Apr 2017||19 Apr 2017||USD||—||45c|
|Paid||Quarterly||–||06 Jan 2017||25 Jan 2017||USD||—||45c|
|Paid||Quarterly||17 Aug 2016||30 Sep 2016||19 Oct 2016||USD||—||40c|
|Paid||Quarterly||18 May 2016||01 Jul 2016||20 Jul 2016||USD||—||40c|
|Paid||Quarterly||–||04 Apr 2016||20 Apr 2016||USD||—||40c|
|Paid||Quarterly||04 Dec 2015||08 Jan 2016||27 Jan 2016||USD||—||38c|
|Paid||Quarterly||18 Aug 2015||02 Oct 2015||21 Oct 2015||USD||—||38c|
|Paid||Quarterly||15 May 2015||06 Jul 2015||22 Jul 2015||USD||—||38c|
|Paid||Quarterly||29 Jan 2015||06 Apr 2015||22 Apr 2015||USD||—||38c|
|Paid||Quarterly||04 Dec 2014||09 Jan 2015||28 Jan 2015||USD||—||33c|
|Paid||Quarterly||15 Aug 2014||03 Oct 2014||22 Oct 2014||USD||—||33c|
|Paid||Quarterly||21 May 2014||07 Jul 2014||23 Jul 2014||USD||—||33c|
|Paid||Quarterly||29 Jan 2014||04 Apr 2014||23 Apr 2014||USD||—||33c|
|Paid||Quarterly||05 Dec 2013||03 Jan 2014||22 Jan 2014||USD||—||30c|
|Paid||Quarterly||20 Aug 2013||27 Sep 2013||16 Oct 2013||USD||—||30c|
|Paid||Quarterly||21 May 2013||28 Jun 2013||17 Jul 2013||USD||—||30c|
|Paid||Quarterly||26 Feb 2013||28 Mar 2013||16 Apr 2013||USD||—||30c|
|Paid||Quarterly||16 Nov 2012||09 Jan 2013||28 Jan 2013||USD||—||30c|
|Paid||Quarterly||–||27 Sep 2012||16 Oct 2012||USD||—||17c|
|Paid||Quarterly||–||29 Jun 2012||18 Jul 2012||USD||—||17c|
|Paid||Quarterly||–||30 Mar 2012||17 Apr 2012||USD||—||17c|
|2021||Sign Up Required|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
Quest Diagnostics, Inc. Optimized Dividend Chart
About Quest Diagnostics, Inc.
Quest Diagnostics Incorporated, incorporated on September 20, 1996, is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers.
Diagnostic Information Services
The Company provides information and insights based on routine, non-routine and advanced clinical testing and anatomic pathology testing, and related services, offering customers the test menu. The Company offers testing solutions, including services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and offer tests in various fields, including endocrinology, immunology, neurology and oncology. It is focused on providing solutions and insights to its customers, based on the testing that it performs and its medical, information and connectivity assets. It provides integrated, diagnostic information services that include both anatomic pathology and clinical laboratory testing, enabling it to offer patients and clinicians a complete analysis. The Company offers access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers, and phlebotomists in physician offices. It provides interpretive consultation through medical and scientific staffs in the industry.
The Company is a provider of infectious disease diagnostic information services. It also provides diagnostic solutions for infectious diseases, including its Focus Diagnostics offerings for Zika, West Nile Virus, Severe acute respiratory syndrome (SARS) and Influenza A H1N1. It is engaged in the neurology diagnostics market, in cardiovascular diagnostic information services, including its CardioIQ offering, and in cancer diagnostics, including its QuestVantage offerings. It is engaged in providing testing for the detection of employee use of drugs of abuse, offering a range of solutions, including urine, hair, blood and oral fluid tests. The Company is a provider of biometric wellness screenings, flu shots and related preventative services. It offers biometric wellness screenings to employer populations through its patient service centers and on-site through its network of mobile examiners and nurses. In addition to a range of screening options, it also offers Blueprint for Wellness and private label reporting, analytics and incentive management services. These services are sold directly to employers and through reseller partnerships with various health plans.
The Company's Quanum health information technology solutions help healthcare organizations and clinicians empower health through diagnostic insights by taking advantage of its information assets, including various years of test result data, and its technology prowess, including its history of providing information technology for diagnostic information services. It provides diagnostic information services in various markets outside the United States. It has laboratory facilities in Gurgaon, India; Mexico City, Mexico, and San Juan, Puerto Rico. It also provides testing services, and inpatient anatomic pathology and medical director services, at hospital laboratories. Its services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
The Company is a provider of risk assessment services for the life insurance industry. In addition, it offers healthcare organizations and clinicians health information technology solutions. ExamOne is a provider of risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies operating outside North America. Its risk assessment services comprise underwriting support services, including data gathering, paramedical examinations and clinical laboratory testing and analytics, designed to assist life insurance companies objectively to evaluate the mortality risks of applicants. As of December 31, 2016, specimen collections and paramedical examinations were performed by its network of paramedical examiners at the applicant's home or workplace, but they also were offered at approximately 600 company patient service centers in the United States and approximately 120 additional locations in North America.
The Company's healthcare information technology offerings include its Quanum EHR product and its ChartMaxx enterprise content management system for hospitals. Its Quanum EHR offering enables clinicians to generate a complete record of a clinical patient encounter, automates and streamlines the clinician's workflow, provides clinical decision support tools, captures patient encounter notes and lab and radiology results and enables communication with patients and other clinicians. Its MyQuest patient healthcare portal enables patients to manage their healthcare and medical information and, among other things, use their smartphone or computer to receive and archive their Quest Diagnostics test results, find a Quest Diagnostics location and schedule appointments.
The Company competes with Laboratory Corporation of America Holdings, Inc.
- Support Services
- United States
- Share Price
- $124.97 (yesterday's closing price)
- Shares in Issue
- 135 million
- Market Cap
- Market Indices
- S&P 500